Jupiter Neurosciences, Inc. (JUNS) stock
JUNSNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.52−0.18 (-10.59%)
Close on Nov 17, 2026Market cap $1.17MP/E –Yield –
Jupiter Neurosciences profit margin
Profit margin (net margin) is net income as a percentage of revenue.
For fiscal 2025 it was -39662.8%.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -39662.8% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -9380.9% | – |
| Q1 FY2026 | Mar 31, 2026 | -11054.9% | – |
See a number that looks wrong?